These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 7958124)

  • 1. The host immune responses to Plasmodium falciparum: Part II--T-cell regulation of human immune responses to Pf155/RESA, a well-defined blood-stage antigen of Plasmodium falciparum: a review.
    Kabilan L
    Indian J Malariol; 1994 Mar; 31(1):12-20. PubMed ID: 7958124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human immune response in Plasmodium falciparum malaria. Synthetic peptides corresponding to known epitopes of the Pf155/RESA antigen induce production of parasite-specific antibodies in vitro.
    Chougnet C; Troye-Blomberg M; Deloron P; Kabilan L; Lepers JP; Savel J; Perlmann P
    J Immunol; 1991 Oct; 147(7):2295-301. PubMed ID: 1717554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of regulatory T-cell responses in humans induced by the P. Falciparum blood stage antigen Pf155/RESA.
    Troye-Blomberg M; Olerup O; Perlmann H; Larsson A; Elghazali G; Fogdell A; Jepsen A; Lepers JP; Pandey JP; Grunewald J
    Behring Inst Mitt; 1994 Dec; (95):97-105. PubMed ID: 7755513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humoral immune responses to the Plasmodium falciparum antigen Pf155 RESA in adults with differential clinical conditions from an Indian zone where malaria is endemic.
    Biswas S; Rao DN; Roy A; Yadav RP; Ghosh SK; Kabilan L
    Southeast Asian J Trop Med Public Health; 1995 Jun; 26(2):219-27. PubMed ID: 8629049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity and in vitro protective efficacy of a polyepitope Plasmodium falciparum candidate vaccine constructed by epitope shuffling.
    Cai Q; Peng G; Bu L; Lin Y; Zhang L; Lustigmen S; Wang H
    Vaccine; 2007 Jul; 25(28):5155-65. PubMed ID: 17548134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmodium falciparum: differential parasite growth inhibition mediated by antibodies to the antigens Pf332 and Pf155/RESA.
    Ahlborg N; Iqbal J; Björk L; Ståhl S; Perlmann P; Berzins K
    Exp Parasitol; 1996 Mar; 82(2):155-63. PubMed ID: 8617342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A longitudinal study of seroreactivities to a major blood stage antigen (Pf155/RESA) of the malaria parasite Plasmodium falciparum in an endemic area of Thailand.
    Chirakalwasan N; Kamol-Ratanakul P; Lertmaharit S; Perlmann H; Perlmann P; Thaitong S
    Southeast Asian J Trop Med Public Health; 1994 Mar; 25(1):25-31. PubMed ID: 7529944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production by activated human T cells of interleukin 4 but not interferon-gamma is associated with elevated levels of serum antibodies to activating malaria antigens.
    Troye-Blomberg M; Riley EM; Kabilan L; Holmberg M; Perlmann H; Andersson U; Heusser CH; Perlmann P
    Proc Natl Acad Sci U S A; 1990 Jul; 87(14):5484-8. PubMed ID: 2115172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of regulatory T cell responses to defined immunodominant T cell epitopes of the Plasmodium falciparum antigen Pf155/RESA.
    Troye-Blomberg M; Sjöberg K; Olerup O; Riley EM; Kabilan L; Perlmann H; Marbiah NT; Perlmann P
    Immunol Lett; 1990 Aug; 25(1-3):129-34. PubMed ID: 1704342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell epitopes in Pf155/RESA, a major candidate for a Plasmodium falciparum malaria vaccine.
    Kabilan L; Troye-Blomberg M; Perlmann H; Andersson G; Högh B; Petersen E; Björkman A; Perlmann P
    Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5659-63. PubMed ID: 2456577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmodium falciparum liver-stage antigen-1 peptide-specific interferon-gamma responses are not suppressed during uncomplicated malaria in African children.
    Luty AJ; Bongartz M; Rezbach P; Faucher JF; Hollingdale MR; Kremsner PG
    Eur Cytokine Netw; 2001; 12(4):647-53. PubMed ID: 11781192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of T epitopes within a potential Plasmodium falciparum vaccine antigen. A study of human lymphocyte responses to repeat and nonrepeat regions of Pf155/RESA.
    Rzepczyk CM; Ramasamy R; Ho PC; Mutch DA; Anderson KL; Duggleby RG; Doran TJ; Murray BJ; Irving DO; Woodrow GC; Parkinson D; Brabin BJ; Alpers MP
    J Immunol; 1988 Nov; 141(9):3197-202. PubMed ID: 2459246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies to a non-repeat region of Plasmodium falciparum antigen Pf155/RESA in individuals from malaria-endemic areas.
    Siddique AB; Ahlborg N; Warsame M; Perlmann P; Berzins K
    Clin Exp Immunol; 1999 Jun; 116(3):493-9. PubMed ID: 10361240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T and B cell responses of Plasmodium falciparum malaria-immune individuals to synthetic peptides corresponding to sequences in different regions of the P. falciparum antigen Pf155/RESA.
    Troye-Blomberg M; Riley EM; Perlmann H; Andersson G; Larsson A; Snow RW; Allen SJ; Houghten RA; Olerup O; Greenwood BM
    J Immunol; 1989 Nov; 143(9):3043-8. PubMed ID: 2478632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of correlation between HLA class II alleles and immune responses to Pf155/ring-infected erythrocyte surface antigen (RESA) from Plasmodium falciparum in Madagascar.
    Migot F; Chougnet C; Perichon B; Danze PM; Lepers JP; Krishnamoorthy R; Deloron P
    Am J Trop Med Hyg; 1995 Mar; 52(3):252-7. PubMed ID: 7535015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humoral and cell-mediated immune responses to the Plasmodium falciparum antigens PF155/RESA and CS protein: seasonal variations in a population recently reexposed to endemic malaria.
    Chougnet C; Deloron P; Lepers JP; Tallet S; Rason MD; Astagneau P; Savel J; Coulanges P
    Am J Trop Med Hyg; 1990 Sep; 43(3):234-42. PubMed ID: 2221217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to a Plasmodium falciparum blood-stage antigen as a tool for predicting the protection levels of two malaria-exposed populations.
    Astagneau P; Roberts JM; Steketee RW; Wirima JJ; Lepers JP; Deloron P
    Am J Trop Med Hyg; 1995 Jul; 53(1):23-8. PubMed ID: 7542843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocyte responses to Plasmodium falciparum ring-infected erythrocyte surface antigen (Pf155/RESA) peptides in individuals with naturally acquired Plasmodium falciparum malaria.
    Udomsangpetch R; Troye-Blomberg M; Brown AE; Thaithong S; Perlmann P; Webster HK
    Am J Trop Med Hyg; 1994 Apr; 50(4):465-71. PubMed ID: 8166354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell reactivity of defined peptides from a major Plasmodium falciparum vaccine candidate: the Pf155/RESA antigen.
    Troye-Blomberg M; Kabilan L; Riley EM; Ortlund J; Andersson G; Perlmann H; Olerup O; Högh B; Petersen E; Snow RW
    Immunol Lett; 1988 Nov; 19(3):229-33. PubMed ID: 3069710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human immune responses to the Plasmodium falciparum ring-infected erythrocyte surface antigen (Pf155/RESA) after a decrease in malaria transmission in Madagascar.
    Migot F; Chougnet C; Raharimalala L; Astagneau P; Lepers JP; Deloron P
    Am J Trop Med Hyg; 1993 Mar; 48(3):432-9. PubMed ID: 8470778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.